Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2025 | 1 | $1.89 | $1.94 | $1.91 |
Q2 2025 | 1 | $1.58 | $1.62 | $1.60 |
Q3 2025 | 1 | $1.46 | $1.50 | $1.47 |
Q4 2025 | 1 | $1.52 | $1.56 | $1.54 |
Q1 2026 | 1 | $1.55 | $1.59 | $1.57 |
Mesa Laboratories, Inc. last posted its earnings results on Tuesday, February 4th, 2025. The company reported $2.67 earnings per share for the quarter, topping analysts' consensus estimates of $1.41 by $1.26. The company had revenue of 62.84 M for the quarter and had revenue of 216.19 M for the year. Mesa Laboratories, Inc. has generated $-47 earnings per share over the last year ($-47.2 diluted earnings per share) and currently has a price-to-earnings ratio of -3.07. Mesa Laboratories, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, June 4th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
02/04/2025 | Q3 2025 | $1.41 | -$0.31 | -1.72 | $58.77 M | $62.84 M |
11/07/2024 | Q2 2025 | $2.48 | $0.63 | -1.85 | $57.88 M | $57.83 M |
08/05/2024 | Q1 2025 | $2.33 | $0.63 | -1.7 | $55.73 M | $58.17 M |
06/28/2024 | Q4 2024 | N/A | -$47.20 | N/A | N/A | $58.90 M |
02/05/2024 | Q3 2024 | $2.04 | $0.39 | -1.65 | $54.90 M | $53.47 M |
11/06/2023 | Q2 2024 | $1.65 | -$0.23 | -1.88 | $55.43 M | $53.17 M |
08/03/2023 | Q1 2024 | $1.67 | -$0.10 | -1.77 | $51.57 M | $50.65 M |
05/30/2023 | Q4 2023 | N/A | $0.11 | N/A | N/A | $55.59 M |
02/06/2023 | Q3 2023 | $2.10 | $0.08 | -2.02 | N/A | $54.29 M |
11/03/2022 | Q2 2023 | $1.39 | $0.25 | -1.14 | $53.24 M | $58.75 M |
08/04/2022 | Q1 2023 | $1.95 | -$0.27 | -2.22 | $52.18 M | $50.45 M |
05/31/2022 | Q4 2022 | $1.88 | -$0.34 | -2.22 | N/A | $58.88 M |
02/03/2022 | Q3 2022 | $1.68 | -$0.39 | -2.07 | N/A | $54.70 M |
11/04/2021 | Q2 2022 | $1.29 | $0.71 | -0.58 | $35.23 M | $35.84 M |
08/05/2021 | Q1 2022 | $1.36 | $0.39 | -0.97 | $34.07 M | $34.92 M |
06/01/2021 | Q4 2021 | $1.48 | $0.76 | -0.72 | N/A | $37.96 M |
02/03/2021 | Q3 2021 | $1.47 | -$0.89 | -2.36 | N/A | $34.17 M |
11/05/2020 | Q2 2021 | $1.07 | $0.52 | -0.55 | $30.28 M | $31.86 M |
08/06/2020 | Q1 2021 | $1.78 | $0.27 | -1.51 | $32.34 M | $29.94 M |
06/01/2020 | Q4 2020 | $2.03 | -$0.38 | -2.41 | N/A | $34.21 M |
Mesa Laboratories, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, June 4th, 2025 based offlast year's report dates.
In the previous quarter, Mesa Laboratories, Inc. (:MLAB) reported $2.67 earnings per share (EPS) to beat the analysts' consensus estimate of $1.41 by $1.26.
The conference call for Mesa Laboratories, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Mesa Laboratories, Inc.'s latest earnings report can be read online.
Mesa Laboratories, Inc. (:MLAB) has a recorded annual revenue of $216.19 M.
Mesa Laboratories, Inc. (:MLAB) has a recorded net income of $-254,246,000.Mesa Laboratories, Inc. has generated $-47.2 earnings per share over the last four quarters.
Mesa Laboratories, Inc. (:MLAB) has a price-to-earnings ratio of -3.07 and price/earnings-to-growth ratio is 2.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED